Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.64% | 178.39 | 1.3% | $493.87m | |
| CELG | Celgene Corporation | -0.78% | 90.20 | 1.3% | $431.91m | |
| GILD | Gilead Sciences, Inc. | -3.23% | 65.04 | 0.9% | $395.98m | |
| ILMN | Illumina, Inc. | -1.79% | 293.20 | 3.5% | $387.83m | |
| BIIB | Biogen Inc. | -0.41% | 231.27 | 1.3% | $347.69m | |
| ARRY | Array BioPharma Inc. | 0.00% | 46.49 | 8.1% | $287.88m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.64% | 298.11 | 2.6% | $250.63m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.00% | 120.80 | 2.0% | $206.12m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -2.22% | 174.13 | 1.9% | $160.59m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.56% | 149.26 | 14.7% | $158.59m | |
| A | Agilent Technologies, Inc. | -2.05% | 68.69 | 1.6% | $152.75m | |
| EXAS | Exact Sciences Corporation | -1.73% | 114.88 | 24.1% | $131.59m | |
| SGEN | Seattle Genetics, Inc. | -2.05% | 75.07 | 6.5% | $108.91m | |
| INCY | Incyte Corporation | -0.95% | 80.54 | 2.5% | $90.89m | |
| BLUE | Bluebird Bio, Inc. | -2.22% | 138.12 | 14.3% | $88.46m |
Company Profile
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system disorders. Its portfolio include late-stage clinical assets targeting psychiatric and movement disorders. The company is headquartered in New York, NY.